|
[1]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Zhou, M., Wang, H., Zeng, X., et al. (2019) Mortality, Morbidity, and Risk Factors in China and Its Provinces, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. The Lancet, 394, 1145-1158. [Google Scholar] [CrossRef]
|
|
[3]
|
Crocetti, L., Bargellini, I. and Cioni, R. (2017) Lo-co-Regional Treatment of HCC: Current Status. Clinical Radiology, 72, 626-635. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Chen, W., Zheng, R., Baade, P.D., et al. (2016) Cancer Statistics in China, 2015. CA: A Cancer Journal for Clinicians, 66, 115-132. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Ko, Y.J., Kwon, Y.M., Kim, K.H., et al. (2012) High-Sensitivity C-Reactive Protein Levels and Cancer Mortality. Cancer Epide-miology, Biomarkers & Prevention, 21, 2076-2086. [Google Scholar] [CrossRef]
|
|
[6]
|
Llovet, J.M., Brú, C. and Bruix, J. (1999) Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification. Seminars in Liver Disease, 19, 329-338. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Greten, F.R. and Grivennikov, S.I. (2019) Inflammation and Cancer: Triggers, Mechanisms, and Consequences. Immunity, 51, 27-41. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Zhou, L., Rui, J.A., Wang, S.B., et al. (2011) Prognostic Fac-tors of Solitary Large Hepatocellular Carcinoma: The Importance of Differentiation Grade. European Journal of Surgical Oncology, 37, 521-525. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Oh, B.S., Jang, J.W., Kwon, J.H., et al. (2013) Prognostic Value of C-Reactive Protein and Neutrophil-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma. BMC Cancer, 13, Article No. 78. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Keizman, D., Ish-Shalom, M., Huang, P., et al. (2012) The Associa-tion of Pre-Treatment Neutrophil to Lymphocyte Ratio with Response Rate, Progression Free Survival and Overall Sur-vival of Patients Treated with Sunitinib for Metastatic Renal Cell Carcinoma. European Journal of Cancer, 48, 202-208. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Tazzyman, S., Lewis, C.E. and Murdoch, C. (2009) Neutrophils: Key Mediators of Tumour Angiogenesis. International Journal of Experimental Pathology, 90, 222-231. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Mantovani, A., Cassatella, M.A., Costantini, C., et al. (2011) Neutrophils in the Activation and Regulation of Innate and Adaptive Immunity. Nature Reviews Immunology, 11, 519-531. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Franco, A.T., Corken, A. and Ware, J. (2015) Platelets at the Inter-face of Thrombosis, Inflammation, and Cancer. Blood, 126, 582-588. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Mano, Y., Aishima, S., Fujita, N., et al. (2013) Tu-mor-Associated Macrophage Promotes Tumor Progression via STAT3 Signaling in Hepatocellular Carcinoma. Pathobi-ology, 80, 146-154. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Cho, E.J., Yu, S.J., Lee, Y.B., et al. (2022) Prognostic Values of Inflammation-Based Scores and Fibrosis Markers in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization. Diagnostics (Basel), 12, Article No. 1170. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Venet, F. and Monneret, G. (2018) Advances in the Under-standing and Treatment of Sepsis-Induced Immunosuppression. Nature Reviews Nephrology, 14, 121-137. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Xiong, S., Dong, L. and Cheng, L. (2021) Neutrophils in Cancer Carcinogenesis and Metastasis. Journal of Hematology & Oncology, 14, Article No. 173. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Lee, W., Ko, S.Y., Mohamed, M.S., et al. (2019) Neutrophils Facilitate Ovarian Cancer Premetastatic Niche Formation in the Omentum. Journal of Experimental Medicine, 216, 176-194. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Gajewski, T.F., Schreiber, H. and Fu, Y.X. (2013) Innate and Adaptive Immune Cells in the Tumor Microenvironment. Nature Immunology, 14, 1014-1022. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Schreiber, R.D., Old, L.J. and Smyth, M.J. (2011) Cancer Immunoediting: In-tegrating Immunity’s Roles in Cancer Suppression and Promotion. Science, 331, 1565-1570. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Motomura, T., Shirabe, K., Mano, Y., et al. (2013) Neutro-phil-Lymphocyte Ratio Reflects Hepatocellular Carcinoma Recurrence after Liver Transplantation via Inflammatory Mi-croenvironment. Journal of Hepatology, 58, 58-64. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Templeton, A.J., Mcnamara, M.G., Šeruga, B., et al. (2014) Prog-nostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis. Journal of the National Cancer Institute, 106, dju124. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Faloppi, L., Bianconi, M., Memeo, R., et al. (2016) Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New. BioMed Research International, 2016, Article ID: 7196280. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Schobert, I.T., Savic, L.J., Chapiro, J., et al. (2020) Neutro-phil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Tumor Response in Hepatocellular Carcinoma after DEB-TACE. European Radiology, 30, 5663-5673. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Chu, H.H., Kim, J.H., Shim, J.H., et al. (2021) Neutro-phil-to-Lymphocyte Ratio as a Biomarker Predicting Overall Survival after Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma. Cancers (Basel), 13, Article No. 2830. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Xiao, W.K., Chen, D., Li, S.Q., et al. (2014) Prognostic Significance of Neutrophil-Lymphocyte Ratio in Hepatocellular Carcinoma: A Meta-Analysis. BMC Cancer, 14, Article No. 117. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Nieswandt, B., Hafner, M., Echtenacher, B., et al. (1999) Lysis of Tumor Cells by Natural Killer Cells in Mice Is Impeded by Platelets. Cancer Research, 59, 1295-1300.
|
|
[28]
|
Xue, T.C., Jia, Q.A., Ge, N.L., et al. (2015) The Platelet-to-Lymphocyte Ratio Predicts Poor Survival in Patients with Huge Hepa-tocellular Carcinoma That Received Transarterial Chemoembolization. Tumor Biology, 36, 6045-6051. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Väyrynen, J.P., Tuomisto, A., Klintrup, K., et al. (2013) Detailed Analysis of Inflammatory Cell Infiltration in Colorectal Cancer. British Journal of Cancer, 109, 1839-1847. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Chanmee, T., Ontong, P., Konno, K., et al. (2014) Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment. Cancers (Basel), 6, 1670-1690. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Xiao, L., Li, L., Chen, G., et al. (2020) The Lymphocyte-to-Monocyte Ratio Could Predict the Efficacy of PD-1 Inhibitors in Patients with Advanced Cancer. Translational Cancer Research, 9, 4111-4120. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Itoh, S., Yugawa, K., Shimokawa, M., et al. (2019) Prognostic Signifi-cance of Inflammatory Biomarkers in Hepatocellular Carcinoma Following Hepatic Resection. BJS Open, 3, 500-508. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Liu, J., Zhang, W., Niu, R., et al. (2020) A Combination of the Preopera-tive Neutrophil-to-Lymphocyte and Lymphocyte-to-Monocyte Ratios as a Useful Predictor of Survival Outcomes Fol-lowing the Transarterial Chemoembolization of Huge Hepatocellular Carcinoma. Saudi Medical Journal, 41, 376-382. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Liu, Y., Shi, M., Chen, S., et al. (2021) Intermediate Stage Hepa-tocellular Carcinoma: Comparison of the Value of Inflammation-Based Scores in Predicting Progression-Free Survival of Patients Receiving Transarterial Chemoembolization. Journal of Cancer Research and Therapeutics, 17, 740-748. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Gong, J., Jiang, H., Shu, C., et al. (2019) Prognostic Value of Lym-phocyte-to-Monocyte Ratio in Ovarian Cancer: A Meta-Analysis. Journal of Ovarian Research, 12, Article No. 51. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Arcone, R., Gualandi, G. and Ciliberto, G. (1988) Identification of Sequences Responsible for Acute-Phase Induction of Human C-Reactive Protein. Nucleic Acids Research, 16, 3195-3207. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Hart, P.C., Rajab, I.M., Alebraheem, M., et al. (2020) C-Reactive Pro-tein and Cancer-Diagnostic and Therapeutic Insights. Frontiers in Immunology, 11, Article ID: 595835. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Kinoshita, A., Onoda, H., Imai, N., et al. (2015) The C-Reactive Protein/Albumin Ratio, a Novel Inflammation-Based Prognostic Score, Predicts Outcomes in Patients with Hepatocellular Carcinoma. Annals of Surgical Oncology, 22, 803-810. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Lu, L.H., Zhong, C., Wei, W., et al. (2021) Lymphocyte-C-Reactive Protein Ratio as a Novel Prognostic Index in Intrahepatic Cholangiocarcinoma: A Multicentre Cohort Study. Liver International, 41, 378-387. [Google Scholar] [CrossRef] [PubMed]
|